Evidence-based analysis of amiodarone efficacy and safety.
about
Pharmacologic management of arrhythmiasOptimal antiarrhythmic drug therapy for electrical stormTedisamil and dofetilide-induced torsades de pointes, rate and potassium dependenceA Physiologically Based Pharmacokinetic Model of Amiodarone and its Metabolite Desethylamiodarone in Rats: Pooled Analysis of Published Data.Azimilide dihydrochloride: a new class III anti-arrhythmic agent.Acute pancreatitis and amiodarone: a case report.Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia.Mechanisms of action of antiarrhythmic drugs relative to the origin and perpetuation of cardiac arrhythmias.Cardiovascular collapse during amiodarone infusion in a hemodynamically compromised child with refractory supraventricular tachycardia.Pharmacologic management of arrhythmias in patients with congenital heart disease.Managing atrial fibrillation in the elderly: critical appraisal of dronedaroneBest practice in primary care pathology: review 4Amiodarone and bepridil inhibit anthrax toxin entry into host cellsAtrial fibrillation after cardiac surgery: pathophysiology and treatment.Ultrastructural Changes in Rat's Atrial Cardiomyocytes After Short Term Administration of Amiodarone and Possible Protective Role of Vitamin E.Atrial fibrillation after cardiac surgery: an evidence-based approach to prevention.Can amiodarone prevent sudden cardiac death in patients with hemodynamically tolerated sustained ventricular tachycardia and coronary artery disease?Antiarrhythmic drug therapy for atrial fibrillation: are the guidelines guiding clinical practice?Implication from randomized trials of rate and rhythm controls on management of patients with persistent atrial fibrillation.Amiodarone: a multifaceted antiarrhythmic drug.Augmentation of late sodium current unmasks the proarrhythmic effects of amiodarone.Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation.Clinical review: treatment of new-onset atrial fibrillation in medical intensive care patients--a clinical frameworkIndications For AF Ablation: Before Or After The Failure Of Antiarrhythmic Drug Therapy?A preliminary assessment of the effects of ATI-2042 in subjects with paroxysmal atrial fibrillation using implanted pacemaker methodology.Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation.Amiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effect?Atrial fibrillation: pathophysiology and current therapy.Amiodarone (Nexterone) injection for the treatment and prophylaxis of frequently recurring ventricular fibrillation.Ischemic Conditioning and Atrial Fibrillation: Hope for a NewTherapy?Altered surfactant homeostasis and alveolar epithelial cell stress in amiodarone-induced lung fibrosis.Management of ventricular tachycardia storm in patients with structural heart disease.Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantation.A randomized placebo-controlled trial with amiodarone for persistent atrial fibrillation in rheumatic mitral stenosis after successful balloon mitral valvuloplasty.RSD1019 suppresses ischaemia-induced monophasic action potential shortening and arrhythmias in anaesthetized rabbits.Effects of metoprolol and amiodarone combination on heart rate, myocardial contractility and coronary flow: Study in isolated perfused rat hearts.Open-state unblock characterizes acute inhibition of I potassium current by amiodarone in guinea pig ventricular myocytes.Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.[Current role of amiodarone in antiarrhythmic therapy].Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
P2860
Q27014008-AF3DC515-D9E1-474E-A124-6A6D5B64F7E2Q27027096-F9495039-15F1-46C4-8D20-D0AD932A38D9Q28361209-B00322A1-921C-4327-956C-A06A48684864Q30985909-C3FAD928-AF02-4822-B067-863D0AF6F4C4Q31522245-E6CC755D-A408-4FEC-B8E2-A35D60F3BD57Q33787811-6BD38653-199F-40E8-9DD3-4814E1734539Q34068720-E74D784F-A1C2-4E45-B5B3-D778F417B5A5Q34308117-9250CFFD-A74C-4CA2-B69F-307C2D0A178AQ35065891-A0D0A43E-4555-4B55-9D7E-BA8DECB8146DQ35631363-7AD5353E-297A-44A3-BE9A-E10701B9BD0CQ35702394-E2418B07-466D-48A1-92CF-588163938428Q35770305-943B668C-52DD-4F69-91B4-7FF854F1E3EAQ35879005-50FCC292-A2C4-4C30-A62E-9DF5412BF51FQ35891042-EB5B9064-67C9-4F22-8D32-5346C2D9732EQ36038058-D16E8101-43BC-4767-89C2-F97764072C4FQ36056774-3ECDB6ED-DE65-445A-BB21-35507BAD63E2Q36249082-8777A7C6-F08E-451F-BF95-72CCE942D3FFQ36441334-0150CFE6-6830-44B2-977F-B2D4A73710FDQ36456002-2A32C3B7-F02D-4FC1-8E7A-CCE4180E5488Q36586992-97FFE328-8114-4EE3-B509-E55A86A029E8Q36628319-90055337-61AF-42F0-B966-B12545951D98Q36713626-53BBBA70-B3CE-4CC0-8971-CD96F2B2F207Q37013160-24097AC8-6A84-447C-8AE1-58D1C7E11C6FQ37115538-49F230B7-951A-4F0D-8210-548078F0AF2CQ37137711-DE27707D-AB72-435C-8A10-79F04F7B7239Q37717862-F2F7CA97-F884-4AC6-A9F3-D0DB087474FBQ37771879-150FEC92-727F-4A09-8C5E-D99BB2658090Q37848443-99FEFF78-8871-477B-AD4D-98397332D4CFQ37979244-56E3C6A4-AC4C-4547-9D30-66D710B60F3DQ38790542-BEB27CE6-27DA-407C-A077-DE6CB295B182Q38962370-288BD368-7DB2-41CB-8A84-763D546D0A55Q39434034-89FB7607-FF8F-40A7-B3F5-91FA225EBA5CQ41043278-B92B7C7A-F7E7-438A-8319-000FE0A670D6Q41571693-9D923DA9-57DF-4898-BDF7-AE08AB276834Q41939170-A5D50979-E716-40A6-A192-2832C3132791Q42112597-65FE80CB-9514-41CB-9016-D790F54FC184Q42476642-ABDDEA98-C937-4D87-816A-FCA6BDB82526Q42780464-A5D49CB4-18EA-4451-B064-5840C49DF45BQ42793548-E791E219-37CE-49B6-9909-BAB2EAE2C87EQ42923039-2E8625F3-F8FE-4D39-8F75-0D1B6B095997
P2860
Evidence-based analysis of amiodarone efficacy and safety.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Evidence-based analysis of amiodarone efficacy and safety.
@ast
Evidence-based analysis of amiodarone efficacy and safety.
@en
type
label
Evidence-based analysis of amiodarone efficacy and safety.
@ast
Evidence-based analysis of amiodarone efficacy and safety.
@en
prefLabel
Evidence-based analysis of amiodarone efficacy and safety.
@ast
Evidence-based analysis of amiodarone efficacy and safety.
@en
P1433
P1476
Evidence-based analysis of amiodarone efficacy and safety.
@en
P2093
Connolly SJ
P304
P356
10.1161/01.CIR.100.19.2025
P407
P577
1999-11-01T00:00:00Z